SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories reports 73% surge in Q2 net profit

22 Oct 2012 Evaluate

Drug firm Unichem Laboratories has reported 73.22% rise in its net profit at Rs 35.07 crore for the second quarter ended September 30, 2012, mainly on account of robust sales. The company had posted net profit of Rs 19.14 crore for the quarter ended September 30, 2011. Total income of the company rose to Rs 264.24 crore for the quarter under consideration, up by 32.90% compared to Rs 198.83 crore for the corresponding period previous fiscal.

Unichem Laboratories is engaged in manufacturing formulations, pharmaceuticals and active pharmaceutical ingredients (APIs). The company was promoted by the late Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Unichem Lab Share Price

350.85 4.85 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×